Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Image Source : PIXABAY Dr Agarwal's Health Care shares are expected to be listed on BSE and NSE on February 5, 2025. Dr Agarwal's Health Care IPO: The subscription window for the initial public ...

In a release sent to Rigzone by the Enverus team recently, the company’s subsidiary, Enverus Intelligence Research (EIR), revealed that 2024 “closed with $105 billion in U.S. upstream deals ...

A week after the first IPO of the year was priced, obesity treatment developer Metsera Inc. and renal specialist Maze Therapeutics Inc. have begun trading on Nasdaq. Metsera (NASDAQ:MTSR) surged 47% ...

NEW YORK -- Nasdaq, a major stock exchange in the world, celebrated the Chinese New Year on Monday afternoon by holding a closing bell ceremony in partnership with the Chinese Consulate General in ...

Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report ... and chronic obstructive pulmonary disease. Receive News & Ratings for Upstream Bio Daily - Enter your email address below to ...

Ascentage Pharma Group Corp. Ltd. has priced the first IPO of the year in the U.S. The offering of 7.32 million shares has the Suzhou, China, and Rockville, Md.-based company looking for gross ...

The IPO of Stallion India Fluorochemicals ran for ... Shares of the company shall be listed on both BSE and NSE. Disclaimer: Business Today provides stock market news for informational purposes ...

Inc. (“AleAnna” or the “Company”) (NASDAQ: ANNA) today will proudly mark its debut on the public market by ringing the closing bell at the NASDAQ Stock Exchange, signaling a vital step ...

The IPO drew significant interest, being subscribed 188 times overall, with non-institutional investors leading at 422.42 times. | Photo Credit: Shares of Stallion India Fluorochemicals will be ...